In This Article:
Noir Expects to See Strong Revenue Growth in 2024 Exceeding $7M, Up from $4.6M in 2023
BOCA RATON, FL / ACCESSWIRE / September 11, 2024 / CYIOS Corp (OTC PINK:CYIO), a publicly traded holding company, is pleased to announce it has successfully closed the strategic acquisition of Noir Medical Supplies, ("Noir") a company specializing in providing top-tier medical equipment and supplies. The acquisition marks a significant milestone for CYIOS with anticipated strong revenue growth in 2024 exceeding $7Million, up from $4.6Million in 2023.
To hear more about this acquisition, we invite you to join company Chairman John O'Shea for a fireside chat today at 4:05pm ET, click here: https://x.com/cyioscorp
John O'Shea, Chairman CYIOS Corporation commented: "We are thrilled to announce the successful closing of Noir Medical Supplies, which we see as a pivotal move to drive revenue growth while creating immediate and long-term shareholder value. With the strong demand for high-quality healthcare products and medical supplies, coupled with our strategic expansion, we are confident in our ability to deliver strong year-over-year revenue growth. The combination of CYIOS's expertise and Noir's diverse product offerings and distribution channels positions us well to capture new opportunities in the healthcare sector. Noir's revenues for 2024 are on target to exceed $7 million USD, reflecting a significant increase from 2023 revenues of $4.6 million. The company is also expecting this year over year revenue growth trend, with positive cash flow, to continue through 2025."
About Noir Medical Supplies
Noir Medical Supplies (https://noirmedicalsupplies.com/) is a rapidly growing provider of high-quality medical supplies and equipment. Established in 2023, Noir has quickly become a trusted name in the healthcare industry, offering a comprehensive range of products including personal protective equipment (PPE), diagnostic devices, and essential healthcare items for clinics, hospitals, and medical professionals. Noir's business model focuses on sourcing and supplying overstock, distressed, and direct purchase inventories to deliver high-quality products at competitive prices. Noir's clientele includes some of the largest healthcare and biotech companies in the United States. Additional information regarding clients served as well as distribution partners can be found on the company's website.
Noir's Mission is to solve inventory challenges for medical institutions and healthcare distributors, ensuring that they have access to the necessary products to operate efficiently and effectively. With a commitment to excellence and customer satisfaction, Noir aims to expand its reach and product offerings, addressing the diverse needs of the healthcare sector across the United States and the Caribbean. Since our inception, Noir has seen consistent revenue growth and is on track to meet its ambitious financial targets.